Category Archives: AZBio News
New research challenges conventional picture of Parkinson’s disease
Parkinson’s disease, the second most common type of progressive dementia after Alzheimer’s disease, affects nearly 1 million people in the U.S. and an estimated 10 million individuals worldwide. Each year, close to 90,000 new cases of Parkinson’s disease are diagnosed in the U.S.Continue reading
GT Medical Technologies, Inc. Names Per Langoe As CEO
Leader in Medical Technology Joins Team to Extend Reach of GammaTile® to More Patients with Brain TumorsContinue reading
Filter Study Dispels Common Myths About Valley Fever
Project in Phoenix metro area is first to look at fungus risk exposure in the airContinue reading
Avery Therapeutics, Inc. Completes In-House cGMP Manufacturing Facility Qualification
TUCSON, ARIZONA – February 13, 2024 – Avery Therapeutics, Inc. (“Avery”), a privately held, pre-clinical stage therapeutics company, proudly announces the successful qualification of their in-house cGMP pilot manufacturing facility for Phase I production in Tucson, AZ.Continue reading
Flinn Foundation adds two Phoenix business leaders to its board of directors
Arizona business leaders Chris Camacho and Adam Goodman—the heads of Greater Phoenix Economic Council and Goodmans, respectively—have been elected to the Flinn Foundation board of directors.Continue reading
Bayer’s Expert Monday’s 2024
Bayer’s Expert Mondays – Knowledge Sharing to Empower Your Innovation Journey and Meet & Greet with Bayer Pharma Scouts.Continue reading
BIO5 Institute’s KEYS Research Internship Program Achieves Record Number of Applicants
[Tucson, Arizona] – The University of Arizona BIO5 Institute’s KEYS Research Internship program is thrilled to announce a groundbreaking surge in applications for its upcoming summer 2024 cohort. This year, the program received an unprecedented 430 applications, showcasing a tremendous interest from Arizona’s high school students aged 16 and older in the field of bioscience.Continue reading
Supporting Innovation – Now is the Time to Speak Up About R&D Expensing
Changes to the tax code revised the way R&D Expenses are treated at tax time. Congress created the policy that is now diverting dollars away from essential R&D. Congress can fix this. You can help them understand why they need to. Continue reading
Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic Testing
Testing offers CBR families the opportunity to proactively seek additional information about their child’s healthContinue reading